| Cancer | Chr | Position | Mutation Type | dbSNP | Protein-change | Allele Freq | RBD |
|---|---|---|---|---|---|---|---|
| ACC | |||||||
| BLCA | |||||||
| BLCA | |||||||
| BRCA | |||||||
| CESC | |||||||
| CESC | |||||||
| CESC | |||||||
| CESC | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| ESCA | |||||||
| GBM | |||||||
| GBM | |||||||
| GBM | |||||||
| GBM | |||||||
| HNSC | |||||||
| HNSC | |||||||
| HNSC | |||||||
| HNSC | |||||||
| HNSC | |||||||
| HNSC | |||||||
| LAML | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUSC | |||||||
| LUSC | |||||||
| OV | |||||||
| READ | |||||||
| READ | |||||||
| READ | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC |
| Cancer | Type | Freq | Q-value |
|---|---|---|---|
| GBM | |||
| KIRC | |||
| LGG | |||
| MESO | |||
| PAAD | |||
| SKCM | |||
| THYM | |||
| UVM |
| Cancer | P-value | Q-value |
|---|---|---|
| KIRC | ||
| STAD | ||
| MESO | ||
| ACC | ||
| UCS | ||
| SKCM | ||
| KIRP | ||
| PAAD | ||
| BLCA | ||
| CESC | ||
| LAML | ||
| UCEC | ||
| GBM | ||
| LGG | ||
| THCA |
| Protein ID | Domain | Pfam ID | E-value | Domain number | Total number |
|---|---|---|---|---|---|
| ENSP00000346810 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000346810 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000353734 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000353734 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000356543 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000356543 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000400060 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000400060 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000400929 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000400929 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000486355 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000486355 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000496979 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000496979 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000497363 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000497363 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000497492 | zf-C2H2 | PF00096.26 | 7.3e-16 | 1 | 2 |
| ENSP00000497492 | zf-C2H2 | PF00096.26 | 7.3e-16 | 2 | 2 |
| ENSP00000496874 | zf-C2H2 | PF00096.26 | 5.5e-15 | 1 | 2 |
| ENSP00000496874 | zf-C2H2 | PF00096.26 | 5.5e-15 | 2 | 2 |
| ENSP00000486763 | zf-C2H2 | PF00096.26 | 3.3e-09 | 1 | 1 |
| ENSP00000356544 | zf-C2H2 | PF00096.26 | 1.2e-08 | 1 | 1 |
| ENSP00000392418 | zf-C2H2 | PF00096.26 | 1.2e-08 | 1 | 1 |
| ENSP00000395960 | zf-C2H2 | PF00096.26 | 1.2e-08 | 1 | 1 |
| ENSP00000496815 | zf-C2H2 | PF00096.26 | 1.2e-08 | 1 | 1 |
| ENSP00000487447 | zf-C2H2 | PF00096.26 | 8.5e-07 | 1 | 1 |
| ENSP00000486752 | zf-C2H2 | PF00096.26 | 1.4e-06 | 1 | 1 |
| ENSP00000486632 | zf-C2H2 | PF00096.26 | 1.5e-06 | 1 | 1 |
| ENSP00000485907 | zf-C2H2 | PF00096.26 | 1.5e-06 | 1 | 1 |
| ENSP00000486632 | zf-met | PF12874.7 | 0.00055 | 1 | 1 |
| ENSP00000487447 | zf-met | PF12874.7 | 0.00069 | 1 | 1 |
| ENSP00000486752 | zf-met | PF12874.7 | 0.00082 | 1 | 1 |
| ENSP00000485907 | zf-met | PF12874.7 | 0.00082 | 1 | 1 |
| PID | Title | Article | Time | Author | Doi |
|---|---|---|---|---|---|
| 15888726 |
| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000631184 | PLAGL1-222 | 491 | - | - | - (aa) | - | - |
| ENST00000649307 | PLAGL1-226 | 3229 | - | ENSP00000496979 | 463 (aa) | - | UPI000006F274 |
| ENST00000417959 | PLAGL1-207 | 1645 | - | ENSP00000395960 | 411 (aa) | - | Q9UM63 |
| ENST00000493898 | PLAGL1-210 | 505 | - | - | - (aa) | - | - |
| ENST00000627449 | PLAGL1-216 | 588 | - | ENSP00000485907 | 73 (aa) | - | A0A0D9SEQ4 |
| ENST00000626294 | PLAGL1-213 | 593 | - | ENSP00000487447 | 80 (aa) | - | A0A0D9SGF7 |
| ENST00000392307 | PLAGL1-205 | 6296 | - | ENSP00000376124 | 252 (aa) | - | Q68DN7 |
| ENST00000444202 | PLAGL1-209 | 3197 | - | ENSP00000400929 | 463 (aa) | - | Q9UM63 |
| ENST00000650125 | PLAGL1-227 | 2910 | - | ENSP00000497363 | 463 (aa) | - | UPI000006F274 |
| ENST00000354765 | PLAGL1-201 | 3663 | - | ENSP00000346810 | 463 (aa) | - | Q9UM63 |
| ENST00000628069 | PLAGL1-217 | 559 | - | - | - (aa) | - | - |
| ENST00000625622 | PLAGL1-211 | 3216 | - | ENSP00000486355 | 463 (aa) | - | Q9UM63 |
| ENST00000647880 | PLAGL1-223 | 2138 | - | ENSP00000496815 | 411 (aa) | - | UPI0000062345 |
| ENST00000626462 | PLAGL1-215 | 587 | - | ENSP00000486752 | 74 (aa) | - | A0A0D9SFM8 |
| ENST00000629890 | PLAGL1-221 | 584 | - | - | - (aa) | - | - |
| ENST00000626373 | PLAGL1-214 | 333 | - | ENSP00000486711 | 12 (aa) | - | A1YLA2 |
| ENST00000367572 | PLAGL1-204 | 2496 | - | ENSP00000356544 | 411 (aa) | - | Q9UM63 |
| ENST00000416623 | PLAGL1-206 | 3237 | - | ENSP00000400060 | 463 (aa) | - | Q9UM63 |
| ENST00000649211 | PLAGL1-225 | 3479 | - | ENSP00000497492 | 463 (aa) | - | UPI000006F274 |
| ENST00000437412 | PLAGL1-208 | 2640 | - | ENSP00000392418 | 411 (aa) | - | Q9UM63 |
| ENST00000360537 | PLAGL1-202 | 4430 | - | ENSP00000353734 | 463 (aa) | - | Q9UM63 |
| ENST00000626022 | PLAGL1-212 | 559 | - | - | - (aa) | - | - |
| ENST00000628630 | PLAGL1-218 | 556 | - | - | - (aa) | - | - |
| ENST00000628651 | PLAGL1-219 | 563 | - | ENSP00000486632 | 102 (aa) | - | A0A0D9SFI7 |
| ENST00000367571 | PLAGL1-203 | 2800 | - | ENSP00000356543 | 463 (aa) | - | Q9UM63 |
| ENST00000629195 | PLAGL1-220 | 723 | - | ENSP00000486763 | 64 (aa) | - | A1YLA1 |
| ENST00000647988 | PLAGL1-224 | 2383 | - | ENSP00000496874 | 173 (aa) | - | - |
| ensgID | Trait | pValue | Pubmed ID |
|---|---|---|---|
| ENSG00000118495 | Bronchodilator Agents | 2E-6 | 26634245 |
| ENSG00000118495 | Lung Volume Measurements | 2E-6 | 26634245 |
| ENSG00000118495 | Bronchodilator Agents | 1E-6 | 26634245 |
| ENSG00000118495 | Lung Volume Measurements | 1E-6 | 26634245 |
| ENSG00000118495 | Bronchodilator Agents | 2E-6 | 26634245 |
| ENSG00000118495 | Lung Volume Measurements | 2E-6 | 26634245 |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000118495 | rs17073303 | 6 | 144034900 | ? | Peanut allergy (maternal genetic effects) | 29489655 | EFO_0007017|EFO_0005939 | ||
| ENSG00000118495 | rs192748541 | 6 | 144052556 | A | Post bronchodilator FEV1/FVC ratio | 26634245 | unit increase | 0.434 | GO_0097366|EFO_0004713 |
| ENSG00000118495 | rs150612539 | 6 | 143952786 | C | Post bronchodilator FEV1/FVC ratio | 26634245 | unit increase | 0.441 | GO_0097366|EFO_0004713 |
| ENSG00000118495 | rs150029151 | 6 | 144025056 | A | Post bronchodilator FEV1/FVC ratio | 26634245 | unit increase | 0.432 | GO_0097366|EFO_0004713 |
| ENSG00000118495 | rs6928827 | 6 | 143994082 | A | Anti-saccade response | 29064472 | EFO_0006874 | ||
| ENSG00000118495 | rs2064495 | 6 | 143948864 | ? | Eosinophil counts | 30595370 | EFO_0004842 |

| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 21873635. | IBA | Function |
| GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 9671765. | IDA | Function |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | - | ISA | Function |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 19274049. | NAS | Function |
| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | 21873635. | IBA | Function |
| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | 9671765. | IDA | Function |
| GO:0003677 | DNA binding | 15888726. | IDA | Function |
| GO:0005654 | nucleoplasm | - | TAS | Component |
| GO:0005794 | Golgi apparatus | - | IDA | Component |
| GO:0006915 | apoptotic process | 9671765. | TAS | Process |
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | - | TAS | Process |
| GO:0007050 | cell cycle arrest | 9184226. | TAS | Process |
| GO:0016604 | nuclear body | 21873635. | IBA | Component |
| GO:0016604 | nuclear body | - | IDA | Component |
| GO:0043231 | intracellular membrane-bounded organelle | - | IDA | Component |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 9671765.15888726. | IDA | Process |
| GO:0046872 | metal ion binding | - | IEA | Function |